Irbesartan and Hydrochlorothiazide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70518-1550
  • Package NDC 70518-1550-0
  • Package NDC 70518-1550-1
  • Application number ANDA203072
  • SPL ID 560707e9-e7a1-7f5e-e063-6294a90a4f07
  • SPL set ID 88aaa2a1-13be-4f56-ace6-66e899028007
  • UNII J0E2756Z7N
  • UNII 0J48LPH2TH
  • RxCUI 310793

What the source publishes

Labeler
REMEDYREPACK INC.
Active ingredients
Irbesartan and Hydrochlorothiazide
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70518-1550_560707e9-e7a1-7f5e-e063-6294a90a4f07
{
  "name": "Irbesartan and Hydrochlorothiazide",
  "splId": "560707e9-e7a1-7f5e-e063-6294a90a4f07",
  "labels": [
    {
      "setId": "88aaa2a1-13be-4f56-ace6-66e899028007",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88aaa2a1-13be-4f56-ace6-66e899028007",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=88aaa2a1-13be-4f56-ace6-66e899028007"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "REMEDYREPACK INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-1550-0)",
      "package_ndc": "70518-1550-0",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20181018"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-1550-1)",
      "package_ndc": "70518-1550-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250827"
    }
  ],
  "productId": "70518-1550_560707e9-e7a1-7f5e-e063-6294a90a4f07",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "70518-1550",
  "deaSchedule": null,
  "genericName": "Irbesartan and Hydrochlorothiazide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "IRBESARTAN",
      "strength": "300 mg/1"
    },
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "strength": "12.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203072",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20181018",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000070",
      "N0000175561",
      "N0000175359",
      "N0000175419",
      "M0471776"
    ],
    "unii": [
      "J0E2756Z7N",
      "0J48LPH2TH"
    ],
    "rxcui": [
      "310793"
    ],
    "spl_set_id": [
      "88aaa2a1-13be-4f56-ace6-66e899028007"
    ],
    "pharm_class_cs": [
      "Thiazides [CS]"
    ],
    "pharm_class_pe": [
      "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
      "Angiotensin 2 Receptor Blocker [EPC]",
      "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_moa": [
      "Angiotensin 2 Receptor Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "REMEDYREPACK INC."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70518-1550_560707e9-e7a1-7f5e-e063-6294a90a4f07"